Genetic Study of Obstructive Azoospermia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In 1% of men with infertility, obstructive azoospermia (OA) may occur in congenital absence of the vas (CAVD) or idiopathic obstructive azoospermia . Many studies have shown that the pathogenic genes of OA are CFTR and ADGRG2 genes, and the inheritance mode is autosomal recessive. Although the conventional assisted reproductive technology(PESA/TESA) can help these patients have children, male patients who carry mutations of the disease-causing genes (CFTR and ADGRG2) will also pass on their mutations to the next generation, which will increase the risk of male offspring infertility. Therefore, genetic detection of CFTR and ADGRG2 genes is very necessary for CAVD patients before assisted reproduction. Genetic diagnosis plays a key role in preventing the disease to the offspring.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Relationship Between Anogenital Distance, Serum AMH, and mTESE in Klinefelter Syndrome

NCT06396117

Azoospermia Anogenital Distance AMH

COMPLETED

Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Couples With Non-obstructive Azoospermia (NOA)

NCT06566599

Non-obstructive Azoospermia Male Infertility

ENROLLING_BY_INVITATION

Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy

NCT05110391

Non-obstructive Azoospermia Hormone Deficiency Hypogonadism, Male +1 more

COMPLETED

Testicular Proteins for Sperm Retrieval Prediction Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia

NCT06154954

Non-obstructive Azoospermia

RECRUITING

Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia.

NCT02900105

Azoospermia, Nonobstructive Oligozoospermia

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Genetic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No sperm was found after centrifugation for 15min for two or more semen tests, and the interval between two tests was at least 2 weeks.
* Blood FSH is normal;
* Hematostatin b is normal;
* Chromosome karyotype is normal or polymorphic;
* Y chromosome microdeletion did not show the deletion:(main locus);
* Biochemical fructose of seminal plasma : less than the normal value;
* PH of semen \<7.2;
* Transscrotal or transrectal ultrasound: normal testicular size(as measured by B ultrasound), presence or dysplasia of vas deferens and epididymis;

Exclusion Criteria

* B ultrasound of urinary system suggested abnormal development;
* Transscrotal or Transrectal ultrasound indicated absence of vas deferens or epididymis or seminal vesicle;
* Physical examination showed the following abnormalities: cryptorchidism, tenderness of testis and epididymis;
* The following medical history: genitourinary tract trauma or surgical history; orchitis; epididymitis; Seminal vesicle disease; mumps;
* Laboratory examination: red and white blood cell elevation of semen routine

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes